Welcome to LookChem.com Sign In|Join Free

CAS

  • or

417724-81-3

Post Buying Request

417724-81-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

417724-81-3 Usage

Description

7-methoxy-4-oxo-1,4-dihydroquinoline-6-carboxamide, also known as 1,4-Dihydro-7-methoxy-4-oxo-6-quinolinecarboxamide, is a metabolite of Lenvatinib (L329400). Lenvatinib is an orally active inhibitor of multiple receptor tyrosine kinases, including VEGF, FGF, and SCF receptors. 7-methoxy-4-oxo-1,4-dihydroquinoline-6-carboxamide plays a significant role in the pharmaceutical industry due to its association with Lenvatinib's therapeutic effects.

Uses

Used in Pharmaceutical Industry:
7-methoxy-4-oxo-1,4-dihydroquinoline-6-carboxamide is used as a metabolite for Lenvatinib, an orally active inhibitor of multiple receptor tyrosine kinases such as VEGF, FGF, and SCF receptors. Its presence in the body indicates the bioavailability and metabolic activity of Lenvatinib, which is crucial for understanding the drug's efficacy and safety profile in treating various diseases, particularly cancer.
Used in Cancer Treatment:
As a metabolite of Lenvatinib, 7-methoxy-4-oxo-1,4-dihydroquinoline-6-carboxamide contributes to the overall therapeutic effect of Lenvatinib in cancer treatment. Lenvatinib's inhibition of multiple receptor tyrosine kinases, including VEGF, FGF, and SCF receptors, helps in suppressing tumor growth and angiogenesis, making it a valuable compound in the fight against cancer.

Check Digit Verification of cas no

The CAS Registry Mumber 417724-81-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,1,7,7,2 and 4 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 417724-81:
(8*4)+(7*1)+(6*7)+(5*7)+(4*2)+(3*4)+(2*8)+(1*1)=153
153 % 10 = 3
So 417724-81-3 is a valid CAS Registry Number.

417724-81-3Relevant articles and documents

Synthesis method of lenvatinib derivative key intermediate

-

Paragraph 0012; 0026-0028, (2021/01/20)

The invention provides a synthesis method of lenvatinib derivative key intermediate 7-methoxy-4-oxo-1, 4-dihydroquinoline-6-carbonitrile, and the synthesis method has the advantages of simple synthesis steps, short reaction time, mild reaction conditions, easiness in purification, high yield and low cost, and a good industrial production prospect.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 417724-81-3